Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Aurobindo Pharma Ltd ( (IN:AUROPHARMA) ) is now available.
Aurobindo Pharma Ltd has announced the incorporation of a new wholly owned subsidiary, Aurobindo Pharma (Malaysia) SDN. BHD., through its subsidiary Helix Healthcare B.V. This strategic move aims to expand the company’s pharmaceutical products business in Malaysia, enhancing its market footprint in the region. The new entity is fully owned by Aurobindo Pharma, with an initial investment of RM 400,000, and is expected to bolster the company’s operations and competitive positioning in the Southeast Asian pharmaceutical market.
More about Aurobindo Pharma Ltd
Aurobindo Pharma Ltd is a prominent player in the pharmaceutical industry, primarily focusing on the development, manufacturing, and marketing of generic pharmaceuticals and active pharmaceutical ingredients. The company has a significant market presence and is known for its extensive range of high-quality medications.
Average Trading Volume: 60,962
Technical Sentiment Signal: Hold
Current Market Cap: 638.1B INR
See more data about AUROPHARMA stock on TipRanks’ Stock Analysis page.